People | September 04, 2024
Enzene appoints new site lead of biologics manufacturing
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Executes the first project for developing and manufacturing a novel anticancer mAb
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Development services for gene and cell therapies is planned to begin first in 2025
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Increased capability to produce medicines for challenging diseases including cancer
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
Subscribe To Our Newsletter & Stay Updated
